News Snapshot:
12 January 2021 Vaccine makers in Asia rush to test jabs against fast-spreading COVID variant Investigations are under way in China and India over fears that new SARS-CoV-2 variants could undermine vaccines. Gayathri Vaidyanathan Google Scholar The Indian vaccine Covaxin was approved for emergency use earlier this month. Credit: Sanjeev Gupta/EPA-EFE/Shutterstock Vaccine makers in India and China are investigating whether their recently approved COVID-19 vaccines are effective against a fast-spreading variant of SARS-CoV-2 now circulating around the world. The move follows similar investigations by the makers of other leading vaccines . Covaxin, developed by the Indian Council of Medical Research...
